Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nazila Shafagati"'
Autor:
Nazila Shafagati, Min J. Koh, Leora Boussi, Hyun J. Park, Robert Stuver, Paul Bain, Francine M. Foss, Changyu Shen, Salvia Jain
Publikováno v:
Blood advances. 6(16)
Optimal treatment strategies for (relapsed and refractory [R/R]) peripheral T-cell lymphoma (PTCL) have not been well defined, and with the approval of several novel single agents (SA), the comparative efficacy of combination chemotherapy (CC) to sin
Autor:
Robert N. Stuver, Changyu Shen, Allison Park, Nazila Shafagati, Paul A. Bain, Leora Boussi, Min Jung Koh, Francine M. Foss, Salvia Jain
Publikováno v:
Blood. 138:1431-1431
Background: Patients with advanced peripheral and cutaneous T-cell lymphomas (PTCL and CTCL) have an unfavorable prognosis . Primary refractoriness to traditional chemotherapy and relapse is common. Few FDA-approved "novel" single agents (SA) are ava
Autor:
Shafagati, Nazila1 (AUTHOR) nshafag1@jhu.edu, Paul, Suman1 (AUTHOR), Rozati, Sima1 (AUTHOR), Sterling, Cole H.1 (AUTHOR) nshafag1@jhu.edu
Publikováno v:
Cancers. Oct2024, Vol. 16 Issue 20, p3489. 22p.
Publisher's Note: Products purchased from Third Party sellers are not guaranteed by the publisher for quality, authenticity, or access to any online entitlements included with the product. SCORE YOUR HIGHEST ON THE USMLE® STEP 1 WITH HELP FROM THE W